Back to top

Tale of the Tape

Zacks Equity Research

BioTime (BTX) Shows Strength: Stock Adds 5.9% in Session
September 26, 2016

BTX ANIP

Trades from $3

BioTime, Inc. (BTX - Free Report) was a big mover last session, as the company saw its shares rise almost 6%. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.80 to $3.59 in the past one-month time frame.

In the past month, the company has not seen any estimate revision and its Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

BioTime currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked stock in the biomedical industry is ANI Pharmaceuticals, Inc. (ANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BTX going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BIOTIME INC (BTX) - free report >>

ANI PHARMACEUT (ANIP) - free report >>